Eradication of Helicobacter pylori heals atrophic corpus gastritis caused by long-term treatment with omeprazole

Virchows Arch. 1999 Jan;434(1):91-4. doi: 10.1007/s004280050310.

Abstract

Long-term treatment with proton pump inhibitors in patients with Helicobacter pylori gastritis can lead to atrophic changes in the corpus mucosa. What is still unclear, however, is whether this atrophy can regress in response to Helicobacter pylori eradication. We report on a male patient with Helicobacter pylori gastritis receiving long-term treatment (4 years) with omeprazole for gastrooesophageal reflux disease, who developed autoaggressive gastritis with progressive atrophy, hypochlorhydria, hypergastrinaemia and nodular ECL-cell hyperplasia. To determine whether these changes might be induced to regress, Helicobacter pylori eradication therapy was administered. Ten months after Helicobacter pylori eradication autoaggressive lymphocytic infiltrates were no longer detectable, and the glands in the corpus mucosa had normalised despite continued treatment with omeprazole - a finding that was confirmed at two further follow-up surveys performed at 6-month intervals. This case report shows that atrophy of the corpus mucosa developing under long-term treatment with a proton pump inhibitor can be cured by eradicating Helicobacter pylori.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Ulcer Agents / adverse effects*
  • Gastritis, Atrophic / chemically induced*
  • Gastritis, Atrophic / pathology
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / pathology
  • Helicobacter pylori / drug effects*
  • Humans
  • Male
  • Omeprazole / adverse effects*

Substances

  • Anti-Ulcer Agents
  • Omeprazole